Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating serum lipid abnormalities in high-priority patients.

D H Blankenhorn1, H N Hodis

  • 1Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

Postgraduate Medicine
|January 1, 1991
PubMed
Summary

Early normalization of serum lipid levels is crucial for patients with vascular disease. Lipid-lowering therapy can reduce mortality and improve atherosclerosis by targeting cholesterol and triglyceride levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menopausal hormone therapy and coronary heart disease: the roller-coaster history.

Climacteric : the journal of the International Menopause Society·2023
Same author

Hormone replacement therapy - where are we now?

Climacteric : the journal of the International Menopause Society·2021
Same author

Determinants of attained estradiol levels in response to oral estradiol plus progesterone therapy.

Climacteric : the journal of the International Menopause Society·2020
Same author

Association of oral estradiol dose/levels with coagulation measures in early/late postmenopausal women.

Climacteric : the journal of the International Menopause Society·2020
Same author

Hierarchical measurement structure in the Women's Health Questionnaire: a confirmatory factor analysis.

Climacteric : the journal of the International Menopause Society·2019
Same author

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?

Climacteric : the journal of the International Menopause Society·2018

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Patients with myocardial, cerebrovascular, or peripheral vascular disease require prompt normalization of serum lipid levels.
  • Clinical trials demonstrate that lipid-lowering therapy can reduce coronary artery disease and overall mortality rates.
  • This therapy has the potential to stabilize or reverse atherosclerosis progression.

Purpose of the Study:

  • To outline the importance and methods of lipid level normalization in patients with vascular disease.
  • To define target lipid levels for effective treatment.
  • To identify therapeutic options for lipid-lowering therapy.

Main Methods:

  • Initiating lipid normalization as soon as possible in affected patients.
  • Implementing lipid-lowering therapy including dietary modification and pharmacologic agents.

Related Experiment Videos

  • Managing nonlipid coronary risk factors concurrently.

    • Main Results:

    • Lipid-lowering therapy effectively reduces coronary artery disease and overall mortality.
    • Target low-density lipoprotein cholesterol levels: ≤130 mg/dL.
    • Target triglyceride levels: ≤150 mg/dL; target high-density lipoprotein cholesterol: ≥52 mg/dL (men), ≥66 mg/dL (women).

    Conclusions:

    • Prompt initiation of lipid normalization is essential for patients with established vascular disease.
    • Achieving specific lipid level targets can significantly improve cardiovascular outcomes.
    • A combination of lifestyle changes and pharmacotherapy is recommended for comprehensive lipid management.